Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart Cart lightblue
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Location


Corporate Headquarters

Vector Laboratories, Inc.
6737 Mowry Ave
Newark, CA 94560
United States

Telephone Numbers



Customer Service: (800) 227-6666 / (650) 697-3600


Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-C139670-100 100 µg (0.5 mg/ml) $503 
Dynactin 3 / DCTN3 Antibody - Goat Anti-DCTN3 Antibody (0.2µg/ml) staining of Mouse (A) and Rat (B) Skeletal Muscle lysates (35µg protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescencence.
Dynactin 3 / DCTN3 Antibody - DCTN3 antibody (0.03 ug/ml) staining of Human Kidney lysate (35 ug protein/ml in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.
Dynactin 3 / DCTN3 Antibody - Goat Anti-DCTN3 Antibody (0.2µg/ml) staining of Mouse (A) and Rat (B) Skeletal Muscle lysates (35µg protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescencence.
Dynactin 3 / DCTN3 Antibody - DCTN3 antibody (0.03 ug/ml) staining of Human Kidney lysate (35 ug protein/ml in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.
1 of 2
2 of 2

Polyclonal Goat anti‑Human Dynactin 3 / DCTN3 Antibody (aa41‑52, WB) LS‑C139670

Polyclonal Goat anti‑Human Dynactin 3 / DCTN3 Antibody (aa41‑52, WB) LS‑C139670

Antibody:
Dynactin 3 / DCTN3 Goat anti-Human Polyclonal (aa41-52) Antibody
Application:
WB, Peptide-ELISA
Reactivity:
Human
Format:
Unconjugated, Unmodified
Price
Catalog Number
$503
LS-C139670-100
Toll Free North America
(800) 227-6666
For Research Use Only

Overview

Antibody:
Dynactin 3 / DCTN3 Goat anti-Human Polyclonal (aa41-52) Antibody
Application:
WB, Peptide-ELISA
Reactivity:
Human
Format:
Unconjugated, Unmodified

Specifications

Description
DCTN3 antibody LS-C139670 is an unconjugated goat polyclonal antibody to human DCTN3 (Dynactin 3) (aa41-52). Validated for Peptide-ELISA and WB.
Target
Human Dynactin 3 / DCTN3
Synonyms
DCTN3 | DCTN-22 | Dynactin 3 | p22 | DCTN22 | Dynactin 3 (p22) | Dynactin light chain | Dynactin subunit 3
Host
Goat
Reactivity
Human (tested or 100% immunogen sequence identity)
Clonality
Polyclonal
Conjugations
Unconjugated
Purification
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Modifications
Unmodified
Immunogen
Peptide with sequence C-QVALGNISSKRE, from the internal region of the protein sequence according to NP_009165.1NP_077324.1.
Epitope
aa41-52
Specificity
Human DCTN3. This antibody is expected to recognize both reported isoforms (NP_009165.1; NP_077324.1).
Applications
  • Western blot (0.03 - 0.1 µg/ml)
  • Peptide Enzyme-Linked Immunosorbent Assay (1:16000)
Usage
Peptide ELISA: antibody detection limit dilution 1:16000. Western blot: Approx 20kD band observed in Human Kidney, Skeletal Muscle and Pancreas lysates (calculated MW of 19.5kD according to NP_077324.1). Recommended concentration: 0.03-0.1 ug/ml.
Presentation
TBS, pH 7.3, 0.02% Sodium Azide, 0.5% BSA
Storage
Aliquot and store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About Dynactin 3 / DCTN3
O75935 NM_007234 NP_009165.1

Publications (0)

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 11/26/2024